Antiola, Kyrie Margo .
HRN: 14-56-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
CEFUROXIME 750MG (VIAL)
11/14/2023
11/21/2023
IV
450 Mg
Q8
PCAP C, BA IN AE
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes